One of COMPUTEX's organizers—TAITRA (Taiwan External Trade Development Council)—today announced that the COMPUTEX 2026 keynote address by Matt Murphy, Chairman and CEO of Marvell Technology,...

The next phase of global finance will be built on tokenized infrastructure that operates continuously across borders, according to Ben Zhou, Co-founder and CEO of Bybit. Speaking at the 2026...

The 4th China International Supply Chain Expo (CISCE), is now 30 days away and will take place from June 22 to 26 at the China International Exhibition Center (Shunyi Venue) in Beijing. The expo...

The America First Business Challenge™ officially unveiled a national entrepreneurship initiative designed to support American entrepreneurs building America First businesses. Funded by the...

EPLive 2026 is a two-day conference that draws the world's top cardiac electrophysiology experts AUSTIN, Texas, May 22, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St....

TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF), ("TOYO" or the "Company"), a solar solution company, today announced that it will participate in The Bank of America Power, Utilities, and Cleantech...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that Caris, the Caris Precision Oncology Alliance® (Caris POA) and...

Management to present corporate update and highlight its next-generation neuroplastogen pipeline TAMPA, Fla., May 22, 2026 /PRNewswire/ -- Psilera, Inc. ("Psilera"), a leading biopharmaceutical...

The Bank of New York Mellon Corporation ("BNY") (NYSE: BNY), a global financial services company, today announced that Dermot McDonogh, Chief Financial Officer, will speak at the Morgan Stanley...

In the news release, 2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination with Chemotherapy as First-line...

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present multiple clinical study results of its novel Nectin-4-targeting...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology,...

The 53rd annual conference Art Gallery and Art Papers programs spotlight groundbreaking work at the intersection of digital art, research, interactive media, and emerging technologies. LOS...

- Data from novel Top1i ADC and T-cell engager platforms highlight potential within solid tumors and blood cancers, including oral presentations in prostate cancer, small cell lung cancer,...

M&T Bank Corporation ("M&T") (NYSE:MTB) will participate in the Morgan Stanley US Financials Conference being held in New York City. Representatives of M&T are scheduled to deliver a presentation...

Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispecific antibody-drug conjugate (ADC), has...

New data demonstrate the potential of the Canopy Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing hospitalizations and increasing time on treatment. NEW YORK, May...

Oral presentation at ASCO Annual Meeting to feature final data from the Phase 3 AcceleRET-Lung clinical trial of GAVRETO® (pralsetinib) as first-line treatment in patients with RET...

Updated efficacy and safety data from a long-term analysis of the Phase 3 INDIGO trial of VORANIGO® (vorasidenib) will be presented in a rapid oral presentation Results from an ongoing Phase 1...

Phase 3 LIBRETTO-432 study evaluating Retevmo (selpercatinib) as adjuvant therapy in RET fusion-positive NSCLC to be featured in the Plenary Session and ASCO press program Investigator-initiated...

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced the presentation of data on iza-bren (izalontamab brengitecan), BL-M14D1, T-Bren (BL-M07D1), and BL-M05D1,...

New patient-reported outcomes data shows improved function and reduced symptom burden with HERNEXEOS® (zongertinib tablets) as an initial treatment option in HER2 (ERBB2)-mutant advanced...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today...

Analog Devices, Inc. (NASDAQ: ADI) today announced that the Company's Executive Vice President & Chief Financial Officer, Richard Puccio, will discuss business topics and trends at the Bank of...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 2026 Jefferies Global...